Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × pertuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Neoplasms 8 HER2-positive Breast Cancer 8 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Early Breast Cancer 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Skin Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Rectal Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Specimen Handling 3 Biopsy 3 Azacitidine 2 venetoclax 1 veliparib 1 pevonedistat 1 peginterferon alfa-2b 1 onvansertib 1 fludarabine phosphate 1 axatilimab 1 Whole-Body Irradiation 1 Valganciclovir 1 Transplantation Conditioning 1 Topotecan 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 High-Energy Shock Waves 1 Geriatric Assessment 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡